• Home
  • Blog
  • Poly pharmacy in Geriatric criteria and danger

Poly pharmacy in Geriatric criteria and danger

0 comments

WEEK 1: DISCUSSION BOARD – POLYPHARMACY

Purpose

The purpose of student discussions is to provide the opportunity for deeper understanding of polypharmacy

Activity Learning Outcomes

Through this discussion, the student will demonstrate the ability to:

  1. Summarize the different polypharmacy definitions found within the literature. (WO1.5) (CO1)
  2. Discuss polypharmacy risk factors (WO1.5) (CO1)
  3. Explain thee actions steps for polypharmacy prevention (WO1.5) (CO1, 7)

Due Date:

The initial posting to the graded collaborative discussions is due by Wednesday, 11:59 p.m. MT.

Peer responses and responses to faculty must be posted prior to the week deadline of Sunday 11:59 MT.

A 10% late penalty will be imposed for discussions posted after the deadline on Wednesday, regardless of the number of days late. NOTHING will be accepted after 11:59pm MT on Sunday (i.e. student will receive an automatic 0).

Total Points Possible:

50 points

Requirements:

Your initial discussion post should include the following:

  1. Identify and discuss 2-3 definitions of polypharmacy (there are multiple definitions). Your textbook can count as 1 reference. You must also include an additional reference from an evidence-based practice journal article or national guideline.
  2. Identify three risk factors that can lead to polypharmacy. Explain the rationale for why each listed item is a risk factor. Risk factors are different than adverse drug reactions. ADRs can be a result of polypharmacy, and is important, but ADRs are not a risk factor.
  3. Explore three action steps that a provider can take to prevent polypharmacy.
  4. Provide an example of how your clinical preceptors have addressed polypharmacy.

DISCUSSION CONTENT

Category

Points

%

Description

Application of Course Knowledge

15

30

1. Includes morethan one definition of polypharmacy

2. Includes three risk factors that can lead to polypharmacy with rationale.

3. Includes three action steps that a provider can take to prevent polypharmacy.

4. Provides an example of how the clinical preceptor has addressed polypharmacy.

Support from Evidence-Based Practice (EBP)

10

20

  1. Discussion post is supported with appropriate, scholarly sources; AND
  2. Sources are published within the last 5 years ; AND
  3. Reference list is provided and in-text citations match; AND
  4. Includes a minimum of one scholarly reference in addition to the textbook

Interactive Dialogue

15

30

  1. Student provides a substantive* response to at least one topic-related post of a peer; AND
  2. Student provides a substantive response to any faculty questions asked regarding theinitial student post.
  3. Evidence from appropriate scholarly sources are included;
  4. Submits a minimum of two posts on two different days.

(*) A substantive post adds new content or insights to the discussion thread and information from student’s original post is not reused in peer or faculty response

40

80%

Total CONTENT Points= 40 pts

DISCUSSION FORMAT

Category

Points

%

Description

Organization

5

10

  1. Discussion is presented in a logical format, AND
  2. Responses are in sequence with the listed bullet points AND
  3. The discussion response is understandable and easy to follow AND
  4. All responses are relevant to the discussion topic.

Grammar, Syntax, Spelling & Punctuation

5

10

Discussion post has minimal grammar, syntax, spelling, punctuation, or APA 7th Edition format errors*

About the Author

Follow me


{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}